|4Apr 5, 4:15 PM ET

Eleven Biotherapeutics, Inc. 4

4 · Eleven Biotherapeutics, Inc. · Filed Apr 5, 2017

Insider Transaction Report

Form 4
Period: 2017-04-03
HURLY STEPHEN A
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-04-03+32,69232,692 total
    Exercise: $2.28Exp: 2027-04-02Common Stock (32,692 underlying)
Footnotes (1)
  • [F1]50% of the shares subject to such option shall vest on grant date, with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date.

Documents

1 file
  • 4
    wf-form4_149142329801580.xmlPrimary

    FORM 4